Rock Springs Capital Management LP - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 35 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,497,950
+17.4%
1,000,0000.0%0.04%
+33.3%
Q2 2023$1,276,050
-5.6%
1,000,0000.0%0.03%
-6.2%
Q1 2023$1,351,500
-14.8%
1,000,0000.0%0.03%
-15.8%
Q4 2022$1,586,500
+12.3%
1,000,0000.0%0.04%
+5.6%
Q3 2022$1,413,000
+6.4%
1,000,0000.0%0.04%
-7.7%
Q2 2022$1,328,000
+0.6%
1,000,0000.0%0.04%
+18.2%
Q1 2022$1,320,000
+5.0%
1,000,0000.0%0.03%
+13.8%
Q4 2021$1,257,000
-5.9%
1,000,0000.0%0.03%
+3.6%
Q3 2021$1,336,000
-0.8%
1,000,0000.0%0.03%
+3.7%
Q2 2021$1,347,000
-0.5%
1,000,0000.0%0.03%
-10.0%
Q1 2021$1,354,000
-2.6%
1,000,0000.0%0.03%
+3.4%
Q4 2020$1,390,000
+0.4%
1,000,0000.0%0.03%
-17.1%
Q3 2020$1,385,000
-17.2%
1,000,0000.0%0.04%
-23.9%
Q2 2020$1,673,000
+30.0%
1,000,0000.0%0.05%
-13.2%
Q1 2020$1,287,000
-16.2%
1,000,0000.0%0.05%
+8.2%
Q4 2019$1,536,000
+12.0%
1,000,0000.0%0.05%
-10.9%
Q3 2019$1,372,000
+4.2%
1,000,0000.0%0.06%
+14.6%
Q2 2019$1,317,000
-2.7%
1,000,0000.0%0.05%
-7.7%
Q1 2019$1,354,000
+13.2%
1,000,0000.0%0.05%
-7.1%
Q4 2018$1,196,000
-29.9%
1,000,0000.0%0.06%
-9.7%
Q3 2018$1,707,000
+18.0%
1,000,0000.0%0.06%
+10.7%
Q2 2018$1,446,0001,000,0000.06%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders